Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients
Open Access
- 19 July 2018
- journal article
- review article
- Published by Wiley in Journal of Diabetes Research
- Vol. 2018, 1-15
Abstract
Type 2 diabetes (T2D) accounts for about 90% of all diabetes patients and incurs a heavy global public health burden. Up to 50% of T2D patients will eventually develop neuropathy as T2D progresses. Diabetic peripheral neuropathy (DPN) is a common diabetic complication and one of the main causes of increased morbidity and mortality of T2D patients. Obstructive sleep apnea (OSA) affects over 15% of the general population and is associated with a higher prevalence of T2D. Growing evidence also indicates that OSA is highly prevalent in T2D patients probably due to diabetic peripheral neuropathy. However, the interrelations among diabetic peripheral neuropathy, OSA, and T2D hitherto have not been clearly elucidated. Numerous molecular mechanisms have been documented that underlie diabetic peripheral neuropathy and OSA, including oxidative stress, inflammation, endothelin-1, vascular endothelial growth factor (VEGF), accumulation of advanced glycation end products, protein kinase C (PKC) signaling, poly ADP ribose polymerase (PARP), nitrosative stress, plasminogen activator inhibitor-1, and vitamin D deficiency. In this review, we seek to illuminate the relationships among T2D, diabetic peripheral neuropathy, and OSA and how they interact with one another. In addition, we summarize and explain the shared molecular mechanisms involved in diabetic peripheral neuropathy and OSA for further mechanistic investigations and novel therapeutic strategies for attenuating and preventing the development and progression of diabetic peripheral neuropathy and OSA in T2D.Keywords
Funding Information
- Natural Science Foundation Project of Jilin Provincial Science and Technology (20160101005JC, 81570652)
- National Natural Science Foundation of China (20160101005JC, 81570652)
This publication has 219 references indexed in Scilit:
- mGluR2/3 activation of the SIRT1 axis preserves mitochondrial function in diabetic neuropathyAnnals of Clinical and Translational Neurology, 2017
- Vitamin D deficiency increases the risk of peripheral neuropathy in Chinese patients with type 2 diabetesDiabetes/Metabolism Research and Reviews, 2016
- Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathyCell Biochemistry and Function, 2012
- Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and managementDiabetes/Metabolism Research and Reviews, 2011
- A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 DiabetesThe Sleep AHEAD StudyEffect of Weight Loss on Obstructive Sleep ApneaArchives of internal medicine (1960), 2009
- Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholaminesClinical Cardiology, 2005
- Advanced glycosylation end products in skin, serum, saliva and urine and its association with complications of patients with Type 2 diabetes mellitusJournal of Endocrinological Investigation, 2005
- Neurovascular disease, antioxidants and glycation in diabetesDiabetes/Metabolism Research and Reviews, 2002
- Taurine Counteracts Oxidative Stress and Nerve Growth Factor Deficit in Early Experimental Diabetic NeuropathyExperimental Neurology, 2001
- Abnormal breathing patterns during sleep in diabetesAnnals of Neurology, 1985